These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8923089)

  • 1. Current and future clinical applications of interferon-gamma in host antimicrobial defense.
    Murray HW
    Intensive Care Med; 1996 Oct; 22 Suppl 4():S456-61. PubMed ID: 8923089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma and host antimicrobial defense: current and future clinical applications.
    Murray HW
    Am J Med; 1994 Nov; 97(5):459-67. PubMed ID: 7977435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-gamma therapy of tuberculosis and related infections.
    Reljic R
    J Interferon Cytokine Res; 2007 May; 27(5):353-64. PubMed ID: 17523867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(5):457-68. PubMed ID: 17147054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial response of a T cell-deficient host to cytokine therapy: effect of interferon-gamma in experimental visceral leishmaniasis in nude mice.
    Murray HW; Hariprashad J; Aguero B; Arakawa T; Yeganegi H
    J Infect Dis; 1995 May; 171(5):1309-16. PubMed ID: 7751708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma, the activated macrophage, and host defense against microbial challenge.
    Murray HW
    Ann Intern Med; 1988 Apr; 108(4):595-608. PubMed ID: 3126690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis.
    Murray HW; Rubin BY; Carriero S; Acosta AM
    J Immunol; 1984 Oct; 133(4):2250-4. PubMed ID: 6432909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma.
    Murray HW; Gellene RA; Libby DM; Rothermel CD; Rubin BY
    J Immunol; 1985 Oct; 135(4):2374-7. PubMed ID: 3928746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human monocyte activation for cytotoxicity against intracellular Leishmania donovani amastigotes: induction of microbicidal activity by interferon-gamma.
    Hoover DL; Nacy CA; Meltzer MS
    Cell Immunol; 1985 Sep; 94(2):500-11. PubMed ID: 3928173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An experimental analysis of the curative action of penicillin in acute bacterial infections. III. The effect of suppuration upon the antibacterial action of the drug.
    SMITH MR; WOOD WB
    J Exp Med; 1956 Apr; 103(4):509-22. PubMed ID: 13306859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.
    Murray HW; Rubin BY; Rothermel CD
    J Clin Invest; 1983 Oct; 72(4):1506-10. PubMed ID: 6415111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcome and analysis of immunological parameters.
    Schwaab T; Heaney JA; Schned AR; Harris RD; Cole BF; Noelle RJ; Phillips DM; Stempkowski L; Ernstoff MS
    J Urol; 2000 Apr; 163(4):1322-7. PubMed ID: 10737537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of interferon-γ genetic and epigenetic variants.
    Smith NL; Denning DW
    Immunology; 2014 Dec; 143(4):499-511. PubMed ID: 25052001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-gamma-activated macrophages.
    Rothermel CD; Rubin BY; Jaffe EA; Murray HW
    J Immunol; 1986 Jul; 137(2):689-92. PubMed ID: 3088106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of host defense mechanism against mycobacterial infection and its application to therapy with biological response modifiers].
    Kawakami K
    Kekkaku; 1994 Nov; 69(11):719-23. PubMed ID: 7837726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony.
    Murray HW; Berman JD; Wright SD
    J Infect Dis; 1988 May; 157(5):973-8. PubMed ID: 2834469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.